Targeting SARS-CoV-2 papain-like protease in the postvaccine era
While vaccines remain at the forefront of global healthcare responses, pioneering
therapeutics against SARS-CoV-2 are expected to fill the gaps for waning immunity. Rapid …
therapeutics against SARS-CoV-2 are expected to fill the gaps for waning immunity. Rapid …
Applications of density functional theory in COVID-19 drug modeling
The rapidly evolving Coronavirus 2019 (COVID-19) pandemic has led to millions of deaths
around the world, highlighting the pressing need to develop effective antiviral …
around the world, highlighting the pressing need to develop effective antiviral …
Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …
[HTML][HTML] Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/3CLpro: molecular docking and simulation studies of three pertinent medicinal …
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-
coronavirus disease 2019 (COVID-19) has raised a severe global public health issue and …
coronavirus disease 2019 (COVID-19) has raised a severe global public health issue and …
HERC5 and the ISGylation pathway: critical modulators of the antiviral immune response
Mammalian cells have developed an elaborate network of immunoproteins that serve to
identify and combat viral pathogens. Interferon-stimulated gene 15 (ISG15) is a 15.2 kDa …
identify and combat viral pathogens. Interferon-stimulated gene 15 (ISG15) is a 15.2 kDa …
Computational evaluation of quinones of Nigella sativa L. as potential inhibitor of dengue virus NS5 methyltransferase
Aedes aegypti is the primary vector for the transmission of the dengue virus, which causes
dengue fever, dengue hemorrhagic illness and dengue shock syndrome. There is now no …
dengue fever, dengue hemorrhagic illness and dengue shock syndrome. There is now no …
Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
The SARS CoV-2 pandemic has affected millions of people around the globe. Despite many
efforts to find some effective medicines against SARS CoV-2, no established therapeutics …
efforts to find some effective medicines against SARS CoV-2, no established therapeutics …
Interactions between SARS coronavirus 2 papain‐like protease and immune system: a potential drug target for the treatment of COVID‐19
S Mahmoudvand, S Shokri - Scandinavian journal of …, 2021 - Wiley Online Library
Coronaviruses (CoVs) are a large family of respiratory viruses which can cause mild to
moderate upper respiratory tract infections. Recently, new coronavirus named as Severe …
moderate upper respiratory tract infections. Recently, new coronavirus named as Severe …
In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease
Global public health has been a critical problem by the sudden increase of the COVID-19
outbreak. The papain-like protease (PLpro) of SARS-CoV-2 is a key promising target for …
outbreak. The papain-like protease (PLpro) of SARS-CoV-2 is a key promising target for …
Novel Drug Design for Treatment of COVID‐19: A Systematic Review of Preclinical Studies
Background. Since the beginning of the novel coronavirus (SARS‐CoV‐2) disease
outbreak, there has been an increasing interest in discovering potential therapeutic agents …
outbreak, there has been an increasing interest in discovering potential therapeutic agents …